Neoadjuvant Considerations for a Patient with HER2+ Early Breast Cancer, November 11, 2015
On October 27th, 2015
Attached you will find an invitation to a program sponsored by Genentech. Lori Ranallo ARNP-BC, CBCN from the University of Kansas Hospital Cancer Center will be speaking about Neoadjuvant considerations for a patient with HER2+ early breast cancer. The program will be at 630 at Red Prime Steakhouse. RSVPs must be sent to maddocks,kathryn@gene.com, douglada@gene.com, castlek@gene.com, or at https://www.genersvp.com using event code 52275.
Click Here for more information.
Attached you will find an invitation to a program sponsored by Genentech. Lori Ranallo ARNP-BC, CBCN from the University of Kansas Hospital Cancer Center will be speaking about Neoadjuvant considerations for a patient with HER2+ early breast cancer. The program will be at 630 at Red Prime Steakhouse. RSVPs must be sent to maddocks,kathryn@gene.com, douglada@gene.com, castlek@gene.com, or at https://www.genersvp.com using event code 52275.
Click Here for more information.
No comments have been posted yet.